Lupande David, Kaishusha David, Mihigo Carine, Itongwa Moise, Yenga Gustave, Katchunga Philippe
Département de Biologie Médicale, Service de Microbiologie/Hôpital Provincial Général de Référence de Bukavu, Université Catholique de Bukavu, B.P 285, Bukavu, RD Congo.
Département de Biologie Médicale, Service de Microbiologie/Cliniques Universitaires de Kinshasa, Université de Kinshasa, B.P 834 KIN XI, RD Congo.
Pan Afr Med J. 2017 Aug 8;27:260. doi: 10.11604/pamj.2017.27.260.12575. eCollection 2017.
In sub-Saharan Africa, diagnostic methods for tuberculosis are inadequate and are essentially based on microscopy. They constitute a real obstacle to the control of tuberculosis. This study aimed to evaluate the performance of GeneXpert MTB/RIF test compared to classical Ziehl-Neelsen staining at the the general referral provincial hospital of Bukavu, in the east of the Democratic Republic of the Congo after 10 months of use.
The results of Ziehl-Neelsen staining and GeneXpert MTB/RIF molecular biology test performed in 452 patients with suspected tuberculosis were collected. This study compares the validity of these different diagnostic tests in the detection of tuberculosis.
In the entire group, the frequency of the pulmonary tuberculosis was 16.3%. The positivity rate was significantly higher in GeneXpert MTB/RIF test than in Ziehl-Neelsen staining in the entire group (15.9% vs 9.3%, p = 0.03) and in HIV seropositive patients (52.0% vs 24.0%; p = 0.007). However, the sensitivity of GeneXpert MTB/RIF test compared to that in Ziehl-Neelsen staining wasn't maximum (95.2%). Finally, GeneXpert MTB/RIF test detected rifampicin resistance in 20.8%.
This study confirms the superiority of GeneXpert MTB/RIF test compared to Ziehl-Neelsen staining in the detection of tuberculosis and in the prediction of multi-resistance. Its systematic use coupled with Ziehl-Neelsen staining would better control tuberculosis in sub-Saharan Africa.
在撒哈拉以南非洲地区,结核病的诊断方法不完善,主要基于显微镜检查。这些方法对结核病的控制构成了实际障碍。本研究旨在评估在刚果民主共和国东部布卡武省综合转诊省级医院使用10个月后,GeneXpert MTB/RIF检测与传统齐-尼氏染色相比的性能。
收集了对452例疑似结核病患者进行的齐-尼氏染色和GeneXpert MTB/RIF分子生物学检测结果。本研究比较了这些不同诊断检测在结核病检测中的有效性。
在整个研究组中,肺结核的发生率为16.3%。GeneXpert MTB/RIF检测在整个研究组(15.9%对9.3%,p = 0.03)以及HIV血清学阳性患者中(52.0%对24.0%;p = 0.007)的阳性率显著高于齐-尼氏染色。然而,与齐-尼氏染色相比,GeneXpert MTB/RIF检测的灵敏度并非最高(95.2%)。最后,GeneXpert MTB/RIF检测发现20.8%的患者存在利福平耐药。
本研究证实了GeneXpert MTB/RIF检测在结核病检测和多耐药预测方面优于齐-尼氏染色。其与齐-尼氏染色联合系统使用将能更好地控制撒哈拉以南非洲地区的结核病。